VanS T349I mutation in Clostridioides difficile infection: phenotypic association and clinical outcomes

Key Points

• The study aims to evaluate clinical outcomes in Clostridioides difficile infection cases related to the VanS T349I mutation.
• Compared clinical outcomes of CDI cases with and without VanS T349I mutation.
• Both groups were treated with vancomycin.
• Utilized phenotypic association for analysis.
• Identified variances in clinical outcomes between mutation-positive and mutation-negative CDI strains.
• Monitored treatment effectiveness of vancomycin in both groups.